Milestone Scientific has a platform technology for the safe delivery of injections, with one application already commercialized and another one (the CompuFlo) close. The health and cost benefits of the CompuFlo are clear, and there is an obvious and large market with 11 million epidurals per year in the US alone. There has been a […]
Milestone Scientific Surges Again
May 5th, 2020 · Comments Off on Milestone Scientific Surges Again
Tags: MLSS
Milestone Scientific Surges Again
April 30th, 2020 · Comments Off on Milestone Scientific Surges Again
Milestone Scientific has a platform technology for the safe delivery of injections, with one application already commercialized and another one (the CompuFlo) close. The health and cost benefits of the CompuFlo are clear, and there is an obvious and large market with 11 million epidurals per year in the US alone. There has been a […]
Tags: MLSS
High-Risk, High-Reward Investors Should Love Milestone Scientific
November 20th, 2019 · Comments Off on High-Risk, High-Reward Investors Should Love Milestone Scientific
The company has a drug delivery technology platform with multiple uses. One is already commercialized for dental practices and produces cash flow for developing and commercializing other applications. Management is concentrating on the CompuFlo Epidural, and the device looks on the edge of a commercial breakthrough. The economic case for hospitals and insurance companies is […]
Tags: MLSS
Milestone Scientific Looks Like Breaking Out
October 3rd, 2019 · Comments Off on Milestone Scientific Looks Like Breaking Out
The company is using its profitable business for dental practices as a cash cow to develop its medical business. The medical business is a platform with multiple applications, but efforts are concentrating on Epidural, where its CompuFlo delivers strong benefits. It looks like the CompuFlo has a fair shot at catching on and the company […]
Tags: MLSS